Valued at a market capitalization of around $87.5 billion, Marriott International, Inc. (MAR) is one of the world’s largest hotel and lodging companies, operating, franchising, and licensing a vast portfolio of hotel brands across more than 130 countries. Headquartered in Bethesda, Maryland, Marriott focuses on managing and franchising properties rather than owning real estate, which makes its business model asset-light and highly scalable.
The global hospitality titan is expected to release its Q1 2026 earnings report next month on Wednesday, May 6, before the market opens. Ahead of the event, Wall Street anticipates earnings of $2.59 per share, representing an increase of 11.6% from $2.32 per share reported in the same quarter last year. It has beaten earnings estimates in three of the past four quarters, while missing on the recent quarter.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For the current fiscal year 2026, analysts expect EPS of $11.67, a solid 16.5% jump from $10.02 reported in fiscal 2025.
www.barchart.comMAR has surged 64.1% over the past 52 weeks, outperforming the S&P 500 Index’s ($SPX) 28.9% rise and the State Street Consumer Discretionary Select Sector SPDR Fund’s (XLY) 22.4% gains over the same time frame.
www.barchart.comOn Mar. 17, shares of Marriott rose more than 2%, benefiting from a broader rally in travel and hotel stocks. The uptick followed commentary from U.S. airline executives highlighting a surge in bookings, as travelers rushed to secure tickets ahead of potential price increases driven by higher fuel costs, signaling solid near-term demand for travel and lodging.
Analysts’ consensus opinion on the stock is moderately optimistic, with a “Moderate Buy” rating overall. Among the 26 analysts covering the stock, 10 are recommending a “Strong Buy,” two advise a “Moderate Buy,” 13 are on the sidelines with a “Hold,” and the remaining one analyst gives a “Strong Sell” for the stock. Although Marriott has rallied strongly and now trades above the average analyst price target of $352.60, the Street-high target of $420 still suggests a potential upside of 14.5% from current levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
This Merck (MRK) Stock Bullish Diagonal Trade Targets a Price of $130 by June 18 S&P Futures Muted After Rally, U.S. Economic Data and Earnings in Focus Should You Chase the Rally in Oracle Stock? A Brown-Forman Acquisition Could Be Brewing. Does That Mean You Should Buy the Dividend Stock Here?